Bliss GVS Pharma donates anti-malaria drugs to Regional Medical Stores, Takoradi, and Tamale Teaching Hospital

Bliss GVS Pharma, a major pharmaceutical company, has made a generous donation. They provided antimalarials and essential medicines worth over GHC 250,000. This donation went to the Regional Medical Stores in Takoradi and the Tamale Teaching Hospital.

The company aims to address public health issues like malaria. Their donations support malaria prevention and control across the country. The donated medications include artemisinin-based combination therapies (ACTs). These include Lonart, P-Alaxin, Gsunate, and Gvither Plus. The World Health Organization recommends these as first-line treatments for uncomplicated malaria.

This initiative is part of Bliss GVS Pharma's “Act for Africa: Malaria-Free Continent Campaign.” It aims to improve access to antimalarial treatments throughout Africa.

Mr. Daniel Bomfeh and Dr. Salifu Alhassan Tia received the donation on behalf of the hospitals. They expressed deep appreciation for Bliss GVS Pharma's generosity. They noted that these drugs would enhance treatment capabilities for patients.

Representatives from Bliss GVS Pharma in both regions also spoke at the event. Mr. Justice Yalley and Mr. Dauda Adam highlighted their commitment to fighting malaria. They emphasized ensuring access to essential medications for everyone.

Dr. Kwesi Biney and Dr. Charles Nkansa Buabeng represented the Pharmaceutical Society of Ghana at the events. They thanked Bliss GVS Pharma for its efforts against malaria. They noted that such donations significantly support national health initiatives.

The donations included a health talk on malaria prevention and treatment. Topics also covered personal and vaginal hygiene at local nursing colleges in Takoradi and Tamale.

Mr. Gagan Sharma, Managing Director of Bliss GVS Pharma, drives this vision forward. His belief in healthcare as a fundamental right inspires their mission against malaria.

Bliss GVS Pharma’s philanthropic efforts highlight the private sector's role in global health equity. Their work supports government efforts to reduce infectious diseases and improve health outcomes for all.